|
|
211 Warren St. Suite 211
Newark, NJ 07103 USA
phone:973-648-0265
fax:973.648.0267
|
|
| Symbol |
Private |
| Founded |
2009 |
| Employees |
|
|
|
| www.hilinlife.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Inventing and marketing original fertility management products primarily for the women's health and family planning industries. |
|
| Management |
| Helen Denise, CEO;
David Stacey, CFO;
Rick Pines, CO of Sales and Marketing;
Russ Case, CO of Production;
Regina Awe, VP of Communication |
| |
|
|
| |
|
| Keywords |
| original fertility, fertility, women's health, family planning, ovulation saliva, fertility monitor |
|
|
|
| Description |
|
Hilin Life Products Inc. is a medical device Company that invents and markets fertility products.KNOWHEN(TM) Monitor with educational kit is a device that will indicate if a woman can conceive on any given day.The timing in this consumer climate combined with our unique talents makes us confident that we can achieve impressive results while improving women's health and become a leader by developing a strong Brand and new products annually. |
|
| Products / Services |
Daily personal use of our saliva fertility lipstick sized devices will let a woman know if she can become pregnant so she act in accordance with her intentions throughout the course of her reproductive years. Educational integration with unique products, books media and services on fertility, infertility and health related issuers. Our vision is to be the recognized global market leader in fertility and family planning products.
|
|
| Technology / Differentiation |
| KNOWHEN(TM)Saliva Fertiloty Monitor with Educational kit is a device that will indicate if a woman can conceive on any given day. Educational kit - Book and CD, made our product different from anyone at the market. KNOWHEN(TM) is the only one at the market FDA cleared, 98% accurate, iParenting Award Winner - quality certification, Patents pending (inventor, design and idea), quick and easy to use, non-intrusive, completely natural, re-usable, no refills to buy. |
|
| Market / Customers |
Globally there are 2 billion women within their reproductive years.We create a potential marketplace for each and every one of them.
Initially we will focus our new product on reaching the 143 million of them in high economy areas like the US,which is a $20 billion market opportunity.Dynamic continuum of customers.Every adolescent female who begins to menstruate is a new potential customer.Women who use one or more devices over the course of their lives until 50th.
|
|
| Competitors / Substitutes / Alternatives |
HLP is the only company that sells a saliva-based monitoring device with an accompanying educational kit. Urine strips, which are messy and unpleasant, are the most common ovulation testing devices on the market. Some saliva devices are sold over the internet, but none is represented in the shops and HLPs monitor has been approved by the FDA.
HLP is not unduly concerned about the competition, since we have a unique product in a market that is immense in scope and opportunity on both a domestic and international scale. And this is unlikely to ever change, since fertility and contraception issues are mainstream medical issues. The key to establishing a robust presence in the fertility market is to embark aggressively on our marketing strategy. HLP has already engaged the services of a prominent New York-based marketing company - Synergy 3 - and they are ready to move into action immediately we can confirm we have sufficient funding to proceed.
|
|
| Strategy |
Strategy
We have a twin-pronged strategy to achieve success: we are both raising equity capital, and we are bootstrapping our way to sales at the same time.
Raising equity will enable HLP to substantially ramp up our pace of development as we will be able to devote greater financial resources to marketing, and creating inventory. In the meantime, we are already in discussions with various sales organizations that wish to represent HLP and our product in various market sectors. Within weeks we expect to start generating real sales. Without additional equity funding, our growth will be slower, but we will build the business on our own nevertheless.
We now have a market-ready product and are in dialogue with potential customers. We are ready to hit the ground running.
In terms of our marketing strategy, we are targeting the retail pharmacy sector, the professional OBGYN community and all five branches of the military in the first instance. We will also be exploring opportunities to expand into international markets in the months ahead.
|
|
| Funding |
| Our PPM indicates we seek to raise $1 million. We have already raised $260,000 and we presently seek to raise the remaining balance. Funding will be directed toward implementing our comprehensive marketing strategy such as advertising, attending major industry trade shows, inventory creation and development of 3rd and 4th generation of KNOWHEN Fertility Products. Funds will also be required for payment of team salaries and for service providers, and for general working capital purposes.
Our executive management team is well-established and in place, and we have already introduced financial controls and cash management procedures which will ensure that investor funds are applied appropriately and optimally, to ensure we get to sales as quickly as possible, and that we can quickly create shareholder value for the business. |
|
| Status |
| Product is in production and we are negotiating deals with Retailers(CVS,Target,Drugstore.com). We will focus strongly on OBGYNs,nurse practitioners,family planning clinics, etc. who can generate revenue from sales to their patients.
To support sales we will employ traditional marketing methods like direct sales and manufactures'representative into drug store chains.We raised $266.000 and plan to raise $250,000 more for operation activity and marketing |
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members